Language selection

Search

Patent 1042463 Summary

Third-party information liability

Some of the information on this Web page has been provided by external sources. The Government of Canada is not responsible for the accuracy, reliability or currency of the information supplied by external sources. Users wishing to rely upon this information should consult directly with the source of the information. Content provided by external sources is not subject to official languages, privacy and accessibility requirements.

Claims and Abstract availability

Any discrepancies in the text and image of the Claims and Abstract are due to differing posting times. Text of the Claims and Abstract are posted:

  • At the time the application is open to public inspection;
  • At the time of issue of the patent (grant).
(12) Patent: (11) CA 1042463
(21) Application Number: 287278
(54) English Title: TERTIARY-ALKYLAMINO-LOWER ACYL-XYLIDIDES
(54) French Title: ALKYLAMINO-ACYL (A CHAINE COURTE)-XYLIDIDES TERTIAIRES
Status: Expired
Bibliographic Data
(52) Canadian Patent Classification (CPC):
  • 260/555.9
(51) International Patent Classification (IPC):
  • C07C 237/20 (2006.01)
  • C07C 231/00 (2006.01)
  • C07C 237/00 (2006.01)
(72) Inventors :
  • TAKMAN, BERTIL H. (Not Available)
  • ADAMS, HERBERT J. F. (Not Available)
  • DI RUBIO, ROBERT L. (Not Available)
  • ANDERSON, JON C. (Not Available)
  • BLAIR, MURRAY R. (JR.) (Not Available)
(73) Owners :
  • ASTRA PHARMACEUTICAL PRODUCTS (Not Available)
(71) Applicants :
(74) Agent:
(74) Associate agent:
(45) Issued: 1978-11-14
(22) Filed Date:
Availability of licence: N/A
(25) Language of filing: English

Patent Cooperation Treaty (PCT): No

(30) Application Priority Data: None

Abstracts

English Abstract



ABSTRACT OF THE DISCLOSURE

The invention is the compound 2-(N-tert.amylamino)-2',6'-
acetoxylidide and its acid addition salts. The compound is a useful inter-
mediate in the production of 2-(N-ethyl-tert. amylamino)-2',6'-acetoxylidine
and 2-(N-n-propyl tert.amylamino)-2',6'-acetoxylidide, which are useful
local anaesthetics having long lasting effects.


Claims

Note: Claims are shown in the official language in which they were submitted.



THE EMBODIMENTS OF THE INVENTION IN WHICH AN EXCLUSIVE
PROPERTY OR PRIVILEGE IS CLAIMED ARE DEFINED AS FOLLOWS:

1. A process for preparing the compound 2-(N-tert.amylamino)-2',
6'-acetoxylidide of formula

Image

which comprises reacting a compound of formula

Image

in which X is chlorine, bromine or iodine, with tert.-amylamine, and if de-
sired converting the product into an acid addition salt.

2. A process according to claim 1 wherein X is chlorine or bromine
the reaction is carried out in the presence of an alkali metal iodide or a
quaternary ammonium iodide.
3. A process according to claim 2 wherein 2-chloro-2',6'-acetoxyl-
idide is reacted with tert.-amylamine in the presence of sodium iodide.

4. A process according to claim 3 wherein the product of the reaction
between 2-chloro-2',6'-acetoxylidide and tert.amylamine is reacted with
hydrogen chloride to obtain the hydrochloride salt.
5. The compound 2-(N-tert.-amylamino)-2',6'-acetoxylidide when made
by a process according to claim 1 or by an obvious chemical equivalent thereof.
6. The compound 2-(N-tert.-amylamino)-2',6'-acetoxylidide hydro-
chloride when made by a process according to claim 4 or by an obvious chemi-
cal equivalent thereof.


Description

Note: Descriptions are shown in the official language in which they were submitted.


This application is a divisiona] of our copending Canadian
patent application Serial No. 164,740, filed February 27~ 1973.
This application Telates to the compound 2-~N-tert.amylamino)-
2',6'-acetoxylidide.
Our copending Canadian patent application Serial No. 164,740
relates to 2-(N-ethyl-tert.amylamino)-2',6'-acetoxylidide and 2-~N-n-propyl-
tert.-amylamino)-2',6'-acetoxylidide, their pharmaceutically acceptable salts
and their use as local anaesthetics. -
This invention relates to a novel compound which is a useful
intermediate in the production of the compounds which are the subject of our
application Serial No. 164,740. The novel compound is 2-~N-tert.-amylamino)-
2',6'-acetoxylidide, of the formula
.
CH,



\ 1 3
CH3 1 2 3


The invention also relates to the acid addition salts of the
compound.
The compound 2-(N-tert. amylamino)-2',6'-acetoxylidide can be
prepared by reacting a compound of formula




~ NH-C-CH~-X
CH3




in which X is chlorine, bromine or iodine, with tert. amylamine.
~hen X is chlorine or bromine the reaction is preferably
carried out in the presence of an alkali metal iodide, for example, sodium
iodide or potassium iodide or a quaternary ammonium iodide.
The compound 2-(N-ter~.-amylamino)-2',6'-acetoxylidide can be
reacted with an alkylating agent to ob~ain 2-(N-ethyl.tert~ amylamino)-2',6'-
acetoxylidide of 2-~N~n-propyl-tert.amylamino)-2'~6'-acetoxylidide in accor-




-- 2 --

dance with our copending application Serial No. 164~740.
The invention is ~urther illustrated in the following Example
showing the preparation of 2-(N-tert.amylamino)-21~6~-aeetoxylidide.
To 400 ml of anhydrous benzene, 18.9 g (0.09S6 mole) 2-chloro-
2l~6t-acetoxylidide~ 20 g (0.2295 mole) tert.amylamine and 1 g. of sodium
iodide were added. The reaction mixture was heated at 100C for 36 hours
in an autoclave. A precipitate was collected and discardedO The resulting
filtrate was stripped of solvent and the yellow oily residue was dissolved
in ether, the undissolved material being collected and discarded~ After
drying (Na2S04) the ether was stripped off in vacuo leaving a yellow oily
liquid which was taken up in dilute hydrochloric acid (~inal pH 2)c The
acidic aqueous phase was washed several times with ether, basified to pH
9.5 with concentrated ammonia, and the preeipitated base extracted with
ether (4xlO0 ml3. The ether extract was dried (Na2S04) and evaporated
n vacuo leaving a yellow oily residue which was distilled in vacuo (b.p.
150C., 0.02 mm.) to give under refrigeration, 16.6 g. of a white solid~
m~p. 54-55.5C~ (The hydrochloride was also prepared and recrystallized
from acetonitrile, m.p. 209-211C.)
Anal. Caled. for C15H24N20: C~ 72-54; H~ 9-74; N~ 28-
Found: C, 72032; H, 9.98; N~ 11.34c I.r, (~Br disc~ hydrochloride) 3150-3120
(m-s; amide, NH streteh); 2710 (s), 2620 (m)~ 2580 (m~ 2440 (m~ and 2417
(m-w) (NH+ streteh)/ .1665 (s; amide I). 1590 (m-w; aromatic~ 1542 (S3 amide
II), 1393 and 1375 (s-m; methyl CH bending), 775 (s~m; 3 adjacent out of
plane aromatic H) cm 1.




:

Representative Drawing

Sorry, the representative drawing for patent document number 1042463 was not found.

Administrative Status

For a clearer understanding of the status of the application/patent presented on this page, the site Disclaimer , as well as the definitions for Patent , Administrative Status , Maintenance Fee  and Payment History  should be consulted.

Administrative Status

Title Date
Forecasted Issue Date 1978-11-14
(45) Issued 1978-11-14
Expired 1995-11-14

Abandonment History

There is no abandonment history.

Owners on Record

Note: Records showing the ownership history in alphabetical order.

Current Owners on Record
ASTRA PHARMACEUTICAL PRODUCTS
Past Owners on Record
None
Past Owners that do not appear in the "Owners on Record" listing will appear in other documentation within the application.
Documents

To view selected files, please enter reCAPTCHA code :



To view images, click a link in the Document Description column. To download the documents, select one or more checkboxes in the first column and then click the "Download Selected in PDF format (Zip Archive)" or the "Download Selected as Single PDF" button.

List of published and non-published patent-specific documents on the CPD .

If you have any difficulty accessing content, you can call the Client Service Centre at 1-866-997-1936 or send them an e-mail at CIPO Client Service Centre.


Document
Description 
Date
(yyyy-mm-dd) 
Number of pages   Size of Image (KB) 
Drawings 1994-05-24 1 13
Claims 1994-05-24 1 35
Abstract 1994-05-24 1 18
Cover Page 1994-05-24 1 30
Description 1994-05-24 2 82